Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Karthik Chakravarthy"'
Autor:
Po-Lan Su, Karthik Chakravarthy, Naoki Furuya, Jeremy Brownstein, Jianhua Yu, Meixiao Long, David Carbone, Zihai Li, Kai He
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-5 (2024)
Abstract DLL3 acts as an inhibitory ligand that downregulates Notch signaling and is upregulated by ASCL1, a transcription factor prevalent in the small-cell lung cancer (SCLC) subtype SCLC-A. Currently, the therapeutic strategies targeting DLL3 are
Externí odkaz:
https://doaj.org/article/d10fc426c38f4600bcf76fa725a89e1b
Autor:
Cong Zeng, John P. Evans, Sarah Reisinger, Jennifer Woyach, Christina Liscynesky, Zeinab El Boghdadly, Mark P. Rubinstein, Karthik Chakravarthy, Linda Saif, Eugene M. Oltz, Richard J. Gumina, Peter G. Shields, Zihai Li, Shan-Lu Liu
Publikováno v:
Cell & Bioscience, Vol 11, Iss 1, Pp 1-6 (2021)
Abstract There is currently a critical need to determine the efficacy of SARS-CoV-2 vaccination for immunocompromised patients. In this study, we determined the neutralizing antibody response in 160 cancer patients diagnosed with chronic lymphocytic
Externí odkaz:
https://doaj.org/article/b0b75e1c41084268a96830ebeb2c2906
Autor:
Mingjia Li, Songzhu Zhao, Gabrielle Lopez, Austin Secor, Parthib Das, Nitya Surya, Madison Grogan, Sandip Patel, Karthik Chakravarthy, Abdul Miah, Daniel Spakowicz, Gabriel Tinoco, Zihai Li, Lai Wei, Kai He, Erin Bertino, Asrar Alahmadi, Regan Memmott, Jacob Kaufman, Peter G. Shields, David P. Carbone, Carolyn J. Presley, Gregory A. Otterson, Dwight H. Owen
Publikováno v:
Cancer Immunology, Immunotherapy.
Autor:
Karthik Chakravarthy, No-Joon Song, Chelsea Bolyard, Kelsi Reynolds, Kevin Weller, Sarah Reisinger, Yi Wang, Anqi Li, Mark Rubinstein, Peter Shields, Zihai Li
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Anqi Li, Yuzhou Chang, No-Joon Song, Xingjun Wu, Dongjun Chung, Brian Riesenberg, Maria Velegraki, Hyunwoo Kwon, Karthik Chakravarthy, Chelsea Bolyard, Yi Wang, Qin Ma, Zihai Li
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Joseph Azar, John P. Evans, Madison Sikorski, Karthik Chakravarthy, Selah McKenney, Ian Carmody, Cong Zeng, Rachael Teodorescu, No Joon Song, Jamie Hamon, Donna Bucci, Maria Velegraki, Chelsea Bolyard, Kevin P. Weller, Sarah Reisinger, Seema A. Bhat, Kami J. Maddocks, Richard J. Gumina, Anastasia N. Vlasova, Eugene M. Oltz, Linda J. Saif, Dongjun Chung, Jennifer A. Woyach, Peter G. Shields, Shan-Lu Liu, Zihai Li, Mark P. Rubinstein
The impact of SARS-CoV2 vaccination in cancer patients remains incompletely understood given the heterogeneity of cancer and cancer therapies. We assessed vaccine-induced antibody response to the SARS-CoV2 Omicron (B.1.1.529) variant in 57 patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a199cca101f36ca6b4473973614a46b3
https://doi.org/10.1101/2022.03.17.22272389
https://doi.org/10.1101/2022.03.17.22272389
Autor:
Cong Zeng, John P. Evans, Karthik Chakravarthy, Panke Qu, Sarah Reisinger, No Joon Song, Mark P. Rubinstein, Peter G. Shields, Zihai Li, Shan-Lu Liu
Publikováno v:
Cancer Cell
Following its emergence in late November of 2020, the SARS-CoV-2 Omicron (B.1.1.529) variant has caused major global public health concerns. We recently demonstrated that in healthy adults the Omicron variant exhibits strong resistance to immunity in
Autor:
James Welker, Juan D Pulido, Andrew T Catanzaro, Carlos D Malvestutto, Zihai Li, Jonathan B Cohen, Eric D Whitman, Dana Byrne, Olivia K Giddings, Jordan E Lake, Joel V Chua, Ella Li, Jian Chen, Xiang Zhou, Kun He, Davis Gates, Amarjot Kaur, Jamie Chen, Hung-Yen Chou, Martin Devenport, Raymond Touomou, Shyamasundaran Kottilil, Yang Liu, Pan Zheng, Jai Thakor, Imaan Khan, Nicole Do, Josephine Faragalla, Andrea Hook, Sarah Kern, Janira V. Ramos, Jason Ward, John Higson, Meena Dam, Dawn Serkin, Pooja Karloopia, Wendy Moore, Mark Scofield, David Jeffery Childers, Jeffrey S. Cantrell, Millie Corgan, Jing Liu, Denise Redvers-Higgins, Hua Han, Jiyun Hou, Yudi Pan, Karyn Tucker, Xiaoyan Zhang, Joel V. Chua, Jennifer Husson, Shivakumar Narayanan, Jaqueline Bran, Ka Wing Joyce Lam, Alicia Jeffrey, Olivia K. Giddings, Jennie Pexa, Mario Becerra, Kathleen W. Gray, Nicole Richmond, Chukwuemeka Nzelibe, Carlos D. Malvestutto, Susan Koletar, Mahdee Sobhanie, Jan Clark, Kelsi Reynolds, Karthik Chakravarthy, Kevin Weller, Mohamed Yusuf, Jennifer Severing, Kelley Barley, Juan D. Pulido, Jennifer C. Fulton, William Gil, M.D. Jeanine, Richmond R.N., Sandy Jones, Kristina Clemmer, Lisa Pedroza, Emily Nicole Davidson, Amanda Logan, Katie Grant, Eric D. Whitman, Jason Kessler, Robert Roland, Rosemary Stefiniw, Molly Maurer, Salome Geene, Christopher F. Buck, Debra Connolly, Patrice Light, Sunanda Baviskar, Yee Won Low, Kyra Michalski, Pamela Giordano, Jennifer Chao, Michelle Williams, Amulya Makkapati, Andrew T. Catanzaro, Jonathan B. Cohen, Mehad Musbah, Pramila Jaladanki, Ying Yuan, Shilpa Rele, Desirae Stewart, Starlet Lewis, Ian Sankar, Nabulungi Kasumba, Kaylia Biney, Elham Hekmat, Jordan E. Lake, Bindu Akkanti, Melissa J. Reimer-McAtee, Marisel Negret Hernandez
Publikováno v:
The Lancet. Infectious diseases. 22(5)
Non-antiviral therapeutic options are required for the treatment of hospitalised patients with COVID-19. CD24Fc is an immunomodulator with potential to reduce the exaggerated inflammatory response to tissue injuries. We aimed to evaluate the safety a
Autor:
Zeinab El Boghdadly, Richard J. Gumina, Christina Liscynesky, Mark P Rubinstein, Shan-Lu Liu, Linda J. Saif, Zihai Li, Peter Shields, Sarah A. Reisinger, Eugene M. Oltz, Karthik Chakravarthy, John P. Evans, Cong Zeng, Jennifer A. Woyach
Publikováno v:
medRxiv
article-version (status) pre
article-version (number) 1
Cell & Bioscience, Vol 11, Iss 1, Pp 1-6 (2021)
Cell & Bioscience
article-version (status) pre
article-version (number) 1
Cell & Bioscience, Vol 11, Iss 1, Pp 1-6 (2021)
Cell & Bioscience
There is currently a critical need to determine the efficacy of SARS-CoV-2 vaccination for immunocompromised patients. In this study, we determined the neutralizing antibody response in 160 cancer patients diagnosed with chronic lymphocytic leukemia
Autor:
Carter Allen, Manuja Gunasena, Qin Ma, Anna E. Vilgelm, Martin Devenport, John P. Evans, Donna Bucci, Shan-Lu Liu, Namal P.M. Liyanage, Amrendra Kumar, Aastha Khatiwada, Chelsea Bolyard, Maria Velegraki, Carlos Malvestutto, Mohamed Yusuf, Anqi Li, Anjun Ma, Kelsi Reynolds, Yuzhou Chang, Pan Zheng, Menglin Xu, Dongjun Chung, No-Joon Song, Brian Riesenberg, Kevin P. Weller, Karthik Chakravarthy, Cong Zeng, Zihai Li, Yang Liu, Zequn Sun
Publikováno v:
Journal of Hematology & Oncology
Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-18 (2022)
Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-18 (2022)
Background Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19) through direct lysis of infected lung epithelial cells, which releases damage-associated molecular patterns and induces a pro-inflammat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbe4bdd0170254f3477974ec2d7784e1
https://doi.org/10.1101/2021.08.18.21262258
https://doi.org/10.1101/2021.08.18.21262258